Qing Tian Niu

Qing Tian Niu

Auto-generated profile, based on publicly available information

Qing Tian Niu

Thousand Oaks Biologics Inc. , Nantong, Jiangsu

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2022 in ImmunoHorizons
Verified
Journal Article
Open access
PDF file
JYjiaan yang
jiaan yang
PZPeng Zhang
Peng Zhang
WCWen Xiang Cheng
Wen Xiang Cheng
GWGang Wu
Gang Wu
QNQing Tian Niu
Qing Tian Niu
LZLianshan Zhang
Lianshan Zhang
Epitope mapping of the interactions between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Abs is challenging because of complexity in protein three-dimensional structures. Protein structure fingerprint technology was applied for epitope mapping of 44 SARS-CoV-2 Abs with three-dimensional structure complexes. The results defined how the epitopes were distributed on SARS-CoV-2 and how the patterns of six CDRs from Abs participated in neutralization. Also, the residue–residue recognition revealed that certain residues had higher frequencies on the interfaces between SARS-CoV-2 and Abs, and the activity correlated with the physicochemical properties of the residues at the interface. Thus, epitope mapping provides significant lead information for development of epitope-based designs for Abs, vaccines, and diagnostic reagents. This is a bioinformatics project of structural data analysis; no animals or cells were used.